missing translation for 'onlineSavingsMsg'
Learn More

ACROBiosystems Inc CHO/Human CD32b Stable Cell Line (High Expression) Development Service

Numéro de catalogue. 502718953
Encompass

Receptors for the Fc region of IgG (Fc R) are members of the Ig superfamily that function in the activation or inhibition of immune responses. Three classes of human Fc Rs: RI (CD64), RII (CD32), and RIII (CD16), which generate multiple isoforms, are recognized. There are three genes for human Fc RII /CD32 (A, B, and C) and one for mouse Fc RII B (CD32B). CD32 is a low affinity receptor for IgG. Low affinity immunoglobulin gamma Fc region receptor II-b (FCGR2B) is also known as CD32b, FCG2, IGFR2. CD32B is expressed on B cells and myeloid dendritic cells. Ligation of CD32B on B cells downregulates antibody production and may, in some circumstances, promote apoptosis. Co-ligation of CD32B on dendritic cells inhibits maturation and blocks cell activation. CD32B may also be a target for monoclonal antibody therapy for malignancies.

Numéro de catalogue. 502718953 Fournisseur ACROBiosystems Inc Code fournisseur SCCHOATP060H2VIALS

Pour de l'aide SVP utiliser la function de clavardage; nous envoyer un couriel à help@thermofisher.com ou appelez le service à la clientèle au 1-800-234-7437.

Receptors for the Fc region of IgG (Fc R) are members of the Ig superfamily that function in the activation or inhibition of immune responses. Three classes of human Fc Rs: RI (CD64), RII (CD32), and RIII (CD16), which generate multiple isoforms, are recognized. There are three genes for human Fc RII /CD32 (A, B, and C) and one for mouse Fc RII B (CD32B). CD32 is a low affinity receptor for IgG. Low affinity immunoglobulin gamma Fc region receptor II-b (FCGR2B) is also known as CD32b, FCG2, IGFR2. CD32B is expressed on B cells and myeloid dendritic cells. Ligation of CD32B on B cells downregulates antibody production and may, in some circumstances, promote apoptosis. Co-ligation of CD32B on dendritic cells inhibits maturation and blocks cell activation. CD32B may also be a target for monoclonal antibody therapy for malignancies.